Age and Comorbidity Considerations Related to Radiotherapy and Chemotherapy Administration

Seminars in Radiation Oncology

Volumn 22, Issue 4, 2012, Pages 277-283

  Rodrigues, George ^a,b   Sanatani, Michael ^a,b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; SUNITINIB; TRASTUZUMAB;

ATAXIA TELANGIECTASIA; BASAL CELL NEVUS SYNDROME; BONE MARROW SUPPRESSION; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CARDIOTOXICITY; COMORBIDITY; CONGESTIVE HEART FAILURE; CROHN DISEASE; CYSTITIS; DERMATITIS; DIABETES MELLITUS; ESOPHAGITIS; FUNCTIONAL STATUS; HUMAN; HYPERTENSION; INTENSITY MODULATED RADIATION THERAPY; MEDICAL DECISION MAKING; MUCOSA INFLAMMATION; MULTIPLE SCLEROSIS; NASOPHARYNX TUMOR; NEPHROTOXICITY; NEUROTOXICITY; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCLERODERMA; SJOEGREN SYNDROME; SKIN EXFOLIATION; THROMBOEMBOLISM; TOXICITY; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; DECISION MAKING; EVIDENCE-BASED MEDICINE; GERIATRIC ASSESSMENT; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; SURVIVAL ANALYSIS;

EID: 84866307717     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2012.05.004     Document Type: Review

References (40)

1. Cancer Facts and Figures 2011 2011, American Cancer Society, American Cancer Society, Atlanta, GA.
2. Piccirillo J.F., Tierney R.M., Costas I., et al. Prognostic importance of comorbidity in a hospital-based cancer registry. jama 2004, 291:2441-2447.
3. Pal S.K., Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 2010, 28:4086-4093.
4. Appelbaum F.R., Gundacker H., Head D.R., et al. Age and acute myeloid leukemia. Blood 2006, 107:3481-3485.
5. Diab S.G., Elledge R.M., Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000, 92:550-556.
6. Sperduto P.W., Chao S.T., Sneed P.K., et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: A multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010, 77:655-661.
7. Sperduto P.W., Berkey B., Gaspar L.E., et al. A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70:510-514.
8. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751.
9. Curran W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three radiation therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993, 85:704-710.
10. Mirimanoff R.O., Gorlia T., Mason W., et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 2006, 24:2563-2569.
11. Mohler J.L. The 2010 NCCN clinical practice guidelines in oncology on prostate cancer. J Natl Compr Cancer Netw 2010, 8:145.
12. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-M156. Cardiovascular Health Study Collaborative Research Group.
13. Yun Y.H., Kim S.H., Lee K.M., et al. Age, sex, and comorbidities were considered in comparing reference data for health-related quality of life in the general and cancer populations. J Clin Epidemiol 2007, 60:1164-1175.
14. Nanda A., Chen M.H., Braccioforte M.H., et al. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction. jama 2009, 302:866-873.
15. Jiralerspong S., Palla S.L., Giordano S.H., et al. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 2009, 27:3297-3302.
16. Frasci G., Lorusso V., Panza N., et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000, 18:2529-2536.
17. Zauderer M., Patil S., Hurria A. Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer. Breast Cancer Res Treat 2009, 117:205-210.
18. Meyerhardt J.A., Catalano P.J., Haller D.G., et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003, 21:433-440.
19. Yancik R., Yates J.W., Cumberlin R. Research recommendations for radiation therapy in older cancer patients. Report from the National Institute on Aging, National Cancer Institute, and American College of Radiology Workshop: Radiation therapy and cancer in older persons. Int J Radiat Oncol Biol Phys 1999, 43:3-5.
20. Kendal W.S. Dying with cancer: The influence of age, comorbidity, and cancer site. Cancer 2008, 112:1354-1362.
21. Vulto A.J., Lemmens V.E., Louwman M.W., et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer 2006, 106:2734-2742.
22. Janssen-Heijnen M.L., Houterman S., Lemmens V.E., et al. Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach. Crit Rev Oncol Hematol 2005, 55:231-240.
23. Coebergh J.W., Janssen-Heijnen M.L., Post P.N., et al. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996. J Clin Epidemiol 1999, 52:1131-1136.
24. Wedding U., Röhrig B., Klippstein A., et al. Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol 2007, 133:945-950.
25. Read W.L., Tierney R.M., Page N.C., et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004, 22:3099-3103.
26. Extermann M., Overcash J., Lyman G.H., et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998, 16:1582-1587.
27. Mao J.J., Armstrong K., Bowman M.A., et al. Symptom burden among cancer survivors: Impact of age and comorbidity. J Am Board Fam Med 2007, 20:434-443.
28. Tyldesley S., Zhang-Salomons J., Groome P.A., et al. Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 2000, 47:469-480.
29. Zachariah B., Balducci L., Venkattaramanabalaji G.V., et al. Radiotherapy for cancer patients aged 80 and older: A study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 1997, 39:1125-1129.
30. Wasil T., Lichtman S.M., Gupta V., et al. Radiation therapy in cancer patients 80 years of age and older. Am J Clin Oncol 2000, 23:526-530.
31. Oguchi M., Ikeda H., Watanabe T., et al. Experiences of 23 patients > or = 90 years of age treated with radiation therapy. Int J Radiat Oncol Biol Phys 1998, 41:407-413.
32. Chon B.H., Loeffler J.S. The effect of nonmalignant systemic disease on tolerance to radiation therapy. Oncologist 2002, 7:136-143.
33. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial. jama 1998, 280:1485-1489.
34. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
35. Lutz S., Berk L., Chang E., et al. Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 79:965-976. American Society for Radiation Oncology (ASTRO).
36. Rodrigues G., Videtic G.M.M., Sur R. Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline. Pract Radiol Oncol 2011, 1:60-71.
37. Gaspar L.E., Mehta M.P., Patchell R.A., et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2010, 96:17-32.
38. Carreca I., Balducci L. Cancer chemotherapy in the older cancer patient. Urol Oncol 2009, 27:633-642.
39. Balducci L., Cohen H.J., Engstrom P.F. National Comprehensive Cancer Network. Senior adult oncology clinical practice guidelines in oncology. J Natl Compr Cancer Netw 2005, 3:572-590.
40. Aliamus V., Adam C., Druet-Cabanac M., et al. Geriatric assessment contribution to treatment decision-making in thoracic oncology [in French]. Rev Mal Respir 2011, 28:1124-1130.